Delivery Order SPE2DB22D1202-SPE2DB25FVLL7
Award Date 9/16/25
Potential Completion Date 9/17/25
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,146.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for ACT-O-VIALS pharmaceutical supplies, with completion targeted for April 23, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $108,033.00 to AmerisourceBergen Drug Corp for Act-O-Vials on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract is non-set-aside and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $8,642.64 to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 3, 2025, with completion expected by September 4, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $14,404.40 delivery order (Contract No. 4569367439) to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $21,606.60 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a small transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and reflects the company's role as a critical vendor for military...
- The Defense Logistics Agency awarded a $173,475.80 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on September 4, 2025, with completion scheduled for September 5, 2025. This competitively awarded, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,331.73 to AmerisourceBergen Drug Corp on August 8, 2025, for ACT-O-VIALS pharmaceutical products. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,714.50 to AmerisourceBergen Drug Corp on August 7, 2025, with completion scheduled for August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The delivery order was issued without a set-aside designation and...
- The Defense Logistics Agency Medical Supply Chain awarded a $22,129.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $40,227 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery order will be performed at AmerisourceBergen's corporate...